한글목차

스캐폴드 기술 동향 및 전망

세계 스캐폴드 기술 시장의 미래는 생명공학 및 제약회사, 계약 연구소, 학술 기관 시장의 기회로 인해 유망합니다. 세계 스캐폴드 기술 시장은 2024년부터 2030년까지 연평균 17.8%의 성장률을 보일 것으로 예상됩니다. 이 시장의 주요 촉진요인은 신체 재건 및 조직 공학에 대한 수요 증가, 생체 재료의 사용 확대, 스캐폴드 기술의 발전입니다.

• Lucintel의 예측에 따르면, 용도별로는 암 발병률의 증가로 인해 새로운 암 예방 및 치료 전략 수립이 촉진됨에 따라 암세포 연구가 예측 기간 동안 가장 큰 부문을 차지할 것으로 예상했습니다.
• 최종 용도 부문에서는 치주 재생 및 연골 합성 같은 조직 공학 분야에서 스캐폴드 기술이 널리 채택되고 있어 학술 기관이 가장 큰 부문이 될 것으로 예상됩니다.
• 지역별로는 암 환자 급증, 장기 이식 증가, 생명공학 기업 및 제약사 확대로 인해 북미가 예측 기간 동안 가장 큰 지역으로 남을 것으로 보입니다.

스캐폴드 기술 시장의 전략적 성장 기회

스캐폴드 기술 시장에는 주요 응용 분야에서 몇 가지 전략적 성장 기회가 존재합니다. 이러한 기회를 활용하면 기술 혁신을 촉진하고 재생의료 분야에서 스캐폴드 기술의 활용을 확대할 수 있습니다.

• 재생의료 : 재생의료 분야에서의 스캐폴드 기술 적용은 큰 성장 잠재력을 가지고 있습니다. 스캐폴드는 구조적 지지력을 제공하고 세포의 성장을 촉진함으로써 조직 복구 및 장기 재생에 중요한 역할을 합니다. 재생의료용 첨단 스캐폴드 개발은 미충족 의료 수요를 충족시키고 시장 확대를 촉진할 수 있습니다.
• 정형외과 응용 분야 : 스캐폴드 기술은 뼈 수복 및 연골 재생과 같은 정형외과 응용 분야에서 성장 기회를 제공합니다. 기계적 특성과 생체적합성이 향상된 첨단 스캐폴드는 골절 및 연골 손상의 치유를 지원하여 정형외과 치료에서 환자의 치료 결과를 개선할 수 있습니다.
• 치과 임플란트 치과 분야에서는 스캐폴드 기술이 치과 수복용 임플란트 및 조직공학 솔루션의 개발을 촉진하고 있습니다. 치과용으로 설계된 스캐폴드는 임플란트의 통합성과 기능성을 향상시켜 구강 위생 치료에서 더 나은 결과를 지원하고 치과용 스캐폴드 기술의 시장을 확대할 수 있습니다.
• 상처 치유 : 스캐폴드 기술은 상처 치유 응용 분야에서 큰 잠재력을 가지고 있습니다. 세포 이동과 조직 재생을 촉진하는 스캐폴드를 개발함으로써 만성 상처와 화상의 치료를 강화할 수 있습니다. 스캐폴드 디자인과 재료의 혁신은 상처 치유 결과를 개선하고 이 분야의 성장을 촉진할 수 있습니다.
• 약물전달 시스템 : 스캐폴드는 약물전달 시스템에도 적용이 검토되고 있습니다. 치료제를 스캐폴드에 통합하면 약물의 방출이 제어되고 국소적으로 방출되어 치료 효과를 높일 수 있습니다. 이 응용 분야는 표적화 및 효능을 개선한 첨단 약물전달 솔루션 개발의 성장 기회를 제공합니다.

스캐폴드 기술 시장의 전략적 성장 기회에는 재생의료, 정형외과, 치과용 임플란트, 상처 치유, 약물전달 시스템 등의 응용 분야가 포함됩니다. 이러한 기회는 혁신과 확장의 가능성을 제공하며, 다양한 의료 분야에서 첨단 스캐폴드 기술의 개발 및 채택을 촉진할 것입니다.

스캐폴드 기술 시장 활성화 요인 및 과제

스캐폴드 기술 시장은 재료과학의 발전, 재생의료 수요 증가, 연구 투자 증가, 규제 역학, 시장 경쟁에 의해 주도되고 있으며, 또한 도전이 되고 있습니다. 이러한 요인을 이해하는 것은 시장을 탐색하고 스캐폴드 기술의 성장과 혁신의 장애물을 극복하는 데 있어 중요한 요소입니다.

스캐폴드 기술 시장을 주도하는 요인은 다음과 같습니다.

• 기술의 발전 : 3D 프린팅, 나노기술, 스마트 재료는 스캐폴드 기술에 혁명을 일으키고 있습니다. 이러한 기술 혁신으로 인해 스캐폴드의 기능, 맞춤형 특성 및 전반적인 성능이 향상되고 조직 재생이 강화되어 새로운 가능성이 열리고 있습니다.
• 재생의료에 대한 수요 증가 : 재생의료와 조직공학에 대한 관심이 높아지면서 보다 정교한 스캐폴드 솔루션에 대한 수요가 증가하고 있습니다. 스캐폴드는 조직 복구 및 장기 재생을 지원하는 데 필수적인 역할을 하고 있으며, 복잡한 질병과 부상을 치료하는 데 도움이 되고 있습니다.
• 연구개발 투자 증가 : 혁신적인 연구개발에 대한 투자로 스캐폴드 개발 산업의 변화를 촉진하고 있습니다. 민간기업, 정부기관, 연구기관에서 신소재, 신기술, 응용 분야 개발에 대한 지원이 증가하여 시장 확대를 촉진하고 있습니다.
• 높아지는 인식과 헬스케어 니즈 : 스캐폴드의 장점에 대한 인식이 높아지고 재생치료에 대한 수요가 증가하면서 시장 성장을 촉진하고 있습니다. 헬스케어의 요구가 계속 진화함에 따라 다양한 질환에 유연하게 대응할 수 있는 첨단 스캐폴드 솔루션이 요구되고 있습니다.
• 혁신을 위한 규제 지원 : 규제 기관은 스커폴드 관련 신기술 도입을 촉진하는 선진적인 규제 환경을 구축하는 데 중요한 역할을 하고 있습니다. 이러한 환경은 시장 진입을 위한 빠른 경로를 만들어 첨단 스캐폴드 솔루션의 개발을 지원합니다.

스캐폴드 기술 시장의 도전과제는 다음과 같습니다.

• 첨단 기술의 높은 비용 : 첨단 기술의 높은 비용 : 특수 재료 및 제조 공정과 같은 첨단 스캐폴드 기술과 관련된 높은 비용으로 인해 많은 사람들이 이러한 솔루션에 접근하기 어려워 보급률이 제한됩니다. 가격에 민감한 시장에서는 첨단 스캐폴드 기술을 감당할 수 없기 때문에 사용이 제한될 수 있습니다.
• 스캐폴드 설계 및 제조의 복잡성 : 스캐폴드 설계 및 제조에는 조직 공학 및 재료 과학의 전문 지식이 필요합니다. 이러한 공정은 종종 복잡하며, 각 스캐폴드의 내구성, 신뢰성 및 제조 중 기능성을 보장하는 것은 품질 문제가 될 수 있습니다. 이러한 문제는 스캐폴드를 이용한 치료의 효율성을 떨어뜨립니다.

기술의 발전, 재생의료에 대한 수요 증가, R&D 투자, 의료 수요 증가, 규제 당국의 지원 등은 스캐폴드 기술 시장을 견인하는 요인 중 하나입니다. 그러나 높은 비용, 설계의 복잡성, 규제 장애물, 일관성 없는 결과와 같은 과제는 여전히 남아 있으며, 이 분야의 성장과 혁신을 촉진하기 위해서는 주의가 필요합니다.

목차

제1장 주요 요약

제2장 세계의 스캐폴드 기술 시장 : 시장 역학

• 소개, 배경, 분류
• 공급망
• 업계 성장 촉진요인과 과제

제3장 2018년부터 2030년까지 시장 동향과 예측 분석

• 거시경제 동향(2018-2023년)과 예측(2024-2030년)
• 세계의 스캐폴드 기술 시장 동향(2018-2023)과 예측(2024-2030)
• 스캐폴드 기술 세계 시장 : 제품별
  • 천연 스캐폴드
  • 합성 스캐폴드
• 세계의 스캐폴드 기술 시장 : 유형별
  • 매크로포러스 스캐폴드
  • 마이크로포러스 스캐폴드
  • 나노 다공질 스캐폴드
  • 고체 스캐폴드
• 세계의 스캐폴드 기술 시장 : 용도별
  • Drug Discovery
  • 재생의료
  • 암세포 조사
  • 줄기세포 조사
• 세계의 스캐폴드 기술 시장 : 최종 용도별
  • 바이오테크놀러지 및 제약회사
  • 임상시험수탁기관
  • 학술기관

제4장 2018년부터 2030년까지 지역별 시장 동향과 예측 분석

• 스캐폴드 기술 세계 시장 : 지역별
• 북미의 스캐폴드 기술 시장
• 유럽의 스캐폴드 기술 시장
• 아시아태평양의 스캐폴드 기술 시장
• 기타 지역의 스캐폴드 기술 시장

제5장 경쟁 분석

• 제품 포트폴리오 분석
• 운영 통합
• Porter's Five Forces 분석

제6장 성장 기회와 전략 분석

• 성장 기회 분석
  • 세계의 스캐폴드 기술 시장 제품별 성장 기회
  • 세계의 스캐폴드 기술 시장 유형별 성장 기회
  • 세계의 스캐폴드 기술 시장 용도별 성장 기회
  • 세계의 스캐폴드 기술 시장 최종 용도별 성장 기회
  • 세계의 스캐폴드 기술 시장 지역별 성장 기회
• 세계의 스캐폴드 기술 시장 최신 동향
• 전략 분석
  • 신제품 개발
  • 세계의 스캐폴드 기술 시장 능력 확대
  • 세계의 스캐폴드 기술 시장 합병, 인수, 합작투자
  • 인증과 라이선싱

제7장 주요 기업 개요

• Synthecon
• Bico
• Lonza
• Thermo Fisher Scientific
• Avantor
• ReproCELL
• 3D Biotek
• Corning
• Becton, Dickinson, &Company
• InSphero

영문목차

Scaffold Technology Trends and Forecast

The future of the global scaffold technology market looks promising with opportunities in the biotechnology & pharmaceutical company, contract research laboratory, and academic institute markets. The global scaffold technology market is expected to grow with a CAGR of 17.8% from 2024 to 2030. The major drivers for this market are increasing demand for procedures in body reconstruction and tissue engineering, growing utilization of biomaterials, as well as, advancements in scaffold technology.

• Lucintel forecasts that, within the application category, cancer cell research will remain the largest segment over the forecast period due to an increase in cancer incidence that has prompted the creation of novel cancer prevention and treatment strategies.
• Within the end-use category, academic institutes will remain the largest segment because the scaffold technology is widely employed in tissue engineering domains like periodontal regeneration and cartilage synthesis.
• In terms of regions, North America will remain the largest region over the forecast period due to a surge in cancer cases, growth in organ transplantations, and expansion of biotechnology and pharmaceutical firms.

Gain valuable insights for your business decisions with our comprehensive 150+ page report.

Emerging Trends in the Scaffold Technology Market

The scaffold technology market is experiencing several emerging trends that reflect advancements in materials science, fabrication techniques, and clinical applications. These trends are reshaping the landscape of tissue engineering and regenerative medicine.

• 3D Bioprinting: The use of 3D bioprinting technology is revolutionizing scaffold production by enabling precise and customizable scaffold designs. With this trend, complex, patient-specific structures can be created to improve tissue regeneration or repair. Additionally, bioprinting allows the incorporation of multiple cell types and growth factors within scaffolds, enhancing their functionality.
• Smart Scaffolds: Smart scaffolds that respond to environmental stimuli, such as changes in pH or temperature, are gaining traction. These materials can adapt to biological conditions, facilitating controlled drug release or specific cellular responses. This makes scaffold-based therapy more effective and further supports dynamic tissue regeneration.
• Nanotechnology Integration: Incorporating nanotechnology into scaffold design is improving material properties and performance. Nanomaterials enhance strength, porosity, biocompatibility, and cell integration, which contribute to better tissue formation within the scaffolds. They also enable the development of special functions, such as antimicrobial properties and enhanced cell interactions, for use in specific types of scaffolds.
• Regenerative Medicine Applications: Scaffold technology is increasingly being applied in regenerative medicine, such as tissue engineering and organ regeneration. The application of advanced biomaterials and scaffold designs has led to the formation of functional tissues and organs, which can be used to treat complex diseases or injuries.
• Personalized Medicine: The shift toward personalized medicine has resulted in a growing demand for customized scaffolds made specifically for individuals. Innovations in 3D scanning and bioprinting technologies have led to the development of tailor-made scaffolds that match a patient's bodily structure, thereby improving treatment outcomes and patient satisfaction.

Emerging trends in the scaffold technology market, including 3D bioprinting, smart materials, biodegradable scaffolds, hybrid scaffolds, and personalized medicine, are advancing the field of tissue engineering. These trends are driving innovation, improving scaffold functionality, and expanding applications in regenerative medicine, ultimately enhancing treatment outcomes and patient care.

Recent Developments in the Scaffold Technology Market

Recent developments in the scaffold technology market highlight significant advancements in materials, fabrication techniques, and clinical applications. These developments are advancing the field of tissue engineering and regenerative medicine.

• Advancements in 3D Bioprinting: The development of three-dimensional (3D) bioprinting has revolutionized scaffold production, enabling highly tailored designs of intricate structures. This means biological architectures, including pore size and spatial cell distribution, can now be precisely controlled, facilitating better tissue integration and regeneration. Bioprinting allows individual patient needs to be met, resulting in personalized scaffolds.
• Development of Smart Scaffolds: Scaffold technology has become smarter by introducing responsive properties that help scaffolds adapt to physiological changes. These smart scaffolds are constructed using materials that can change their characteristics under environmental conditions, such as pH or temperature variations. This innovation allows dynamic treatment approaches, such as controlled drug delivery or live monitoring of tissue development.
• Integration of Nanotechnology: Nanotechnology enhances various material features at the nanoscale, improving scaffold design. Nanomaterials incorporated into the scaffold improve strength, biocompatibility, and cellular interactions. Furthermore, scaffolds can now be developed with additional functionalities, such as antimicrobial properties, which contribute significantly to overall treatment outcomes.
• Focus on Biodegradable Materials: Recent developments have focused on using biodegradable materials in scaffold technology. Biodegradable scaffolds eliminate the need for secondary surgeries, thus reducing long-term complications and supporting natural tissue growth. Advances in biodegradable polymers and composites have increased the efficacy and safety of scaffold-based treatments.
• Increased Research in Regenerative Medicine: More studies are being conducted on integrating scaffold technology into regenerative medicine applications. Significant innovations include combining scaffolds with stem cells and growth factors, leading to tissue repair or regeneration. This has opened up prospects for functional tissue or organ replacements to address complex medical conditions or injuries.

Recent developments in the scaffold technology market, including advancements in 3D printing, biomaterials, regulatory frameworks, manufacturing techniques, and collaborative research, are driving innovation and improving the field of tissue engineering. These developments enhance scaffold functionality, support regulatory compliance, and expand the potential applications of scaffold technologies.

Strategic Growth Opportunities for Scaffold Technology Market

The scaffold technology market presents several strategic growth opportunities across key applications. Capitalizing on these opportunities can drive innovation and expand the use of scaffold technologies in regenerative medicine.

• Regenerative Medicine: The application of scaffold technology in regenerative medicine offers significant growth potential. Scaffolds play a crucial role in tissue repair and organ regeneration by providing structural support and promoting cell growth. Developing advanced scaffolds for regenerative medicine can address unmet medical needs and drive market expansion.
• Orthopedic Applications: Scaffold technology presents growth opportunities in orthopedic applications, such as bone repair and cartilage regeneration. Advanced scaffolds with enhanced mechanical properties and biocompatibility can support the healing of bone fractures and cartilage injuries, improving patient outcomes in orthopedic treatments.
• Dental Implants: In the dental field, scaffold technology is advancing the development of implants and tissue engineering solutions for dental repairs. Scaffolds designed for dental applications can improve the integration and functionality of implants, supporting better outcomes in oral health treatments and expanding the market for dental scaffold technologies.
• Wound Healing: Scaffold technology has significant potential in wound healing applications. Developing scaffolds that promote cell migration and tissue regeneration can enhance the treatment of chronic wounds and burns. Innovations in scaffold design and materials can improve wound healing outcomes and drive growth in this segment.
• Drug Delivery Systems: Scaffolds are also being explored for use in drug delivery systems. Incorporating therapeutic agents into scaffolds allows for controlled and localized drug release, enhancing treatment efficacy. This application offers growth opportunities in developing advanced drug delivery solutions with improved targeting and effectiveness.

Strategic growth opportunities in the scaffold technology market include applications in regenerative medicine, orthopedics, dental implants, wound healing, and drug delivery systems. These opportunities offer potential for innovation and expansion, driving the development and adoption of advanced scaffold technologies in various medical fields.

Scaffold Technology Market Driver and Challenges

The scaffold technology market is driven and challenged by advancements in material science, increasing demand for regenerative medicine, rising research investments, regulatory dynamics, and market competition. To navigate the market and overcome hurdles to growth and innovation in scaffold technology, it is important to understand these factors.

The factors responsible for driving the scaffold technology market include:

• Technological Advancements: 3D printing, nanotechnology, and smart materials are revolutionizing scaffold technology. These innovations have improved scaffold functionality, customization properties, and overall performance, which has enhanced tissue regeneration and opened up new possibilities.
• Increasing Demand for Regenerative Medicine: The increasing emphasis on regenerative medicine and tissue engineering has fueled the demand for more sophisticated scaffold solutions. Scaffolds play an essential role in supporting tissue repair and organ regeneration, which help in treating complex medical conditions and injuries.
• Rising Investment in Research and Development: Investment in innovative research is promoting changes in the scaffold development industry. There is increased support from private companies, governmental organizations, and research institutions toward developing new materials, technologies, and applications, thereby facilitating market expansion.
• Growing Awareness and Healthcare Needs: Increasing awareness of the benefits of scaffolding, along with rising incidences of regenerative therapies, are propelling market growth. Advanced scaffold solutions are needed to flexibly address different medical conditions, as healthcare needs continue to evolve.
• Regulatory Support for Innovation: Regulatory bodies play a crucial role in creating advanced regulatory environments that encourage the introduction of new technologies related to scaffolds. These environments help create fast pathways to market entry, thus supporting the development of advanced scaffold solutions.

Challenges in the scaffold technology market include:

• High Costs of Advanced Technologies: High costs associated with advanced scaffold technologies, including specialized materials and manufacturing processes, make it difficult for many to access these solutions, limiting their adoption rates. Price-sensitive markets may find advanced scaffolds unaffordable, thus limiting their availability.
• Complexity of Scaffold Design and Production: Designing and producing scaffolds requires expertise in tissue engineering and materials science. These processes are often complex, and ensuring that each scaffold is durable, reliable, and functional during manufacturing poses quality challenges. These issues can reduce the efficiency of scaffold-based treatments.

Advances in technology, increased demand for regenerative medicine, investment in R&D activities, growing healthcare needs, and regulatory support are some of the factors driving the scaffold technology market. However, challenges such as high costs, design complexity, regulatory hurdles, and inconsistent outcomes remain, requiring attention to drive growth and innovation in the sector.

List of Scaffold Technology Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies scaffold technology companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the scaffold technology companies profiled in this report include-

• Synthecon
• Bico
• Lonza
• Thermo Fisher Scientific
• Avantor
• ReproCELL
• 3D Biotek
• Corning
• Becton, Dickinson, &Company
• InSphero

Scaffold Technology by Segment

The study includes a forecast for the global scaffold technology by product type, type, application, end use, and region.

Scaffold Technology Market by Product Type [Analysis by Value from 2018 to 2030]:

• Natural Scaffold
• Synthetic Scaffold

Scaffold Technology Market by Type [Analysis by Value from 2018 to 2030]:

• Macro-Porous Scaffolds
• Micro-Porous Scaffolds
• Nano-Porous Scaffolds
• Solid Scaffolds

Scaffold Technology Market by Application [Analysis by Value from 2018 to 2030]:

• Drug Discovery
• Regenerative Medicine
• Cancer Cell Research
• Stem Cell Research

Scaffold Technology Market by End Use [Analysis by Value from 2018 to 2030]:

• Biotechnology & Pharmaceutical Companies
• Contract Research Laboratories
• Academic Institutes

Scaffold Technology Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Scaffold Technology Market

Scaffold technology is crucial for tissue engineering and regenerative medicine, offering innovative solutions for repairing or replacing damaged tissues and organs. Recent advancements reflect the growing emphasis on improving biomaterials, fabrication techniques, and clinical applications across different regions. Below is an overview of recent developments in the scaffold technology market in the United States, China, Germany, and India.

• United States: Recent developments in the U.S. scaffold technology market include advancements in 3D bioprinting and personalized scaffolds. Research is focused on 3D printing patient-specific scaffolds to enhance tissue regeneration. Additionally, there is ongoing work to incorporate smart biomaterials into scaffolds, enabling them to sense biological signals and improving their functionality in regenerative medicine.
• China: In China, the scaffold technology market is experiencing growth driven by increased investment in regenerative medicine and tissue engineering. Innovations include the development of composite scaffolds made from polymers combined with natural substances, which improve scaffold performance and support tissue regeneration. There is also a growing emphasis on scaling up production capabilities to enable broader market access.
• Germany: Germany's progress in scaffold technology is driven by cutting-edge research on biodegradable materials and advanced manufacturing techniques. These innovations focus on creating scaffolds with enhanced mechanical properties and controlled degradation rates. Additionally, Germany is exploring the combination of scaffold treatments with other therapeutic solutions, such as gene therapy or cellular therapy, to achieve better outcomes.
• India: In India, the scaffold technology market is evolving with a focus on affordable and scalable solutions. Recent advances include the development of cost-effective yet biocompatible materials, along with the establishment of research collaborations aimed at boosting scaffold performance. Scaffold technology is also being explored to address large-scale tissue engineering challenges in clinical settings.

Features of the Global Scaffold Technology Market

Market Size Estimates: Scaffold technology market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Scaffold technology market size by product type, type, application, end use, and region in terms of value ($B).

Regional Analysis: Scaffold technology market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different product type, type, application, end use, and regions for the scaffold technology market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the scaffold technology market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this market or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the scaffold technology market by product type (natural scaffold and synthetic scaffold), type (macro-porous scaffolds, micro-porous scaffolds, nano-porous scaffolds, and solid scaffolds), application (drug discovery, regenerative medicine, cancer cell research, and stem cell research), end use (biotechnology & pharmaceutical companies, contract research laboratories, and academic institutes), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Scaffold Technology Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global Scaffold Technology Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global Scaffold Technology Market by Product Type
  • 3.3.1: Natural Scaffold
  • 3.3.2: Synthetic Scaffold
• 3.4: Global Scaffold Technology Market by Type
  • 3.4.1: Macro-Porous Scaffolds
  • 3.4.2: Micro-Porous Scaffolds
  • 3.4.3: Nano-Porous Scaffolds
  • 3.4.4: Solid Scaffolds
• 3.5: Global Scaffold Technology Market by Application
  • 3.5.1: Drug Discovery
  • 3.5.2: Regenerative Medicine
  • 3.5.3: Cancer Cell Research
  • 3.5.4: Stem Cell Research
• 3.6: Global Scaffold Technology Market by End Use
  • 3.6.1: Biotechnology & Pharmaceutical Companies
  • 3.6.2: Contract Research Laboratories
  • 3.6.3: Academic Institutes

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global Scaffold Technology Market by Region
• 4.2: North American Scaffold Technology Market
  • 4.2.1: North American Market by Application: Drug Discovery, Regenerative Medicine, Cancer Cell Research, and Stem Cell Research
  • 4.2.2: North American Market by End Use: Biotechnology & Pharmaceutical Companies, Contract Research Laboratories, and Academic Institutes
• 4.3: European Scaffold Technology Market
  • 4.3.1: European Market by Application: Drug Discovery, Regenerative Medicine, Cancer Cell Research, and Stem Cell Research
  • 4.3.2: European Market by End Use: Biotechnology & Pharmaceutical Companies, Contract Research Laboratories, and Academic Institutes
• 4.4: APAC Scaffold Technology Market
  • 4.4.1: APAC Market by Application: Drug Discovery, Regenerative Medicine, Cancer Cell Research, and Stem Cell Research
  • 4.4.2: APAC Market by End Use: Biotechnology & Pharmaceutical Companies, Contract Research Laboratories, and Academic Institutes
• 4.5: ROW Scaffold Technology Market
  • 4.5.1: ROW Market by Application: Drug Discovery, Regenerative Medicine, Cancer Cell Research, and Stem Cell Research
  • 4.5.2: ROW Market by End Use: Biotechnology & Pharmaceutical Companies, Contract Research Laboratories, and Academic Institutes

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Scaffold Technology Market by Product Type
  • 6.1.2: Growth Opportunities for the Global Scaffold Technology Market by Type
  • 6.1.3: Growth Opportunities for the Global Scaffold Technology Market by Application
  • 6.1.4: Growth Opportunities for the Global Scaffold Technology Market by End Use
  • 6.1.5: Growth Opportunities for the Global Scaffold Technology Market by Region
• 6.2: Emerging Trends in the Global Scaffold Technology Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Scaffold Technology Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Scaffold Technology Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Synthecon
• 7.2: Bico
• 7.3: Lonza
• 7.4: Thermo Fisher Scientific
• 7.5: Avantor
• 7.6: ReproCELL
• 7.7: 3D Biotek
• 7.8: Corning
• 7.9: Becton, Dickinson, &Company
• 7.10: InSphero